Search Ontology:
ChEBI
prostaglandin E2
- Term ID
- CHEBI:15551
- Synonyms
-
- (15S)-prostaglandin E2
- (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
- (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
- (Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
- Cervidil
- Cerviprime
- Cerviprost
- Dinoproston
- dinoprostona
- dinoprostone
- dinoprostonum
- Enzaprost E
- Glandin-E2
- Minprositin E2
- Minprostin E2
- PGE2
- Prepidil
- Propess
- Prostaglandin E2
- Prostarmon E
- Prostenone
- Prostin
- Prostin E2
- U 12062
- U-12,062
- U-12062
- Definition
- Prostaglandin F2α in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.
- References
-
- beilstein:2224724
- cas:363-24-6
- drugbank:DB00917
- drugcentral:913
- foodb.food:FDB022498
- hmdb:HMDB0001220
- kegg.compound:C00584
- kegg.drug:D00079
- lincs.smallmolecule:LSM-42919
- lipidmaps:LMFA03010003
- patent:DE2011969
- patent:GB851827
- patent:NL6505799
- patent:US3598858
- pdb-ccd:P2E
- pubmed:11279302
- pubmed:12746806
- pubmed:12859290
- pubmed:14499495
- pubmed:14535055
- pubmed:14703707
- pubmed:15542928
- pubmed:15661432
- pubmed:16405508
- pubmed:16787416
- pubmed:16978535
- pubmed:20671299
- pubmed:2403792
- pubmed:24501112
- pubmed:32898608
- pubmed:33271839
- pubmed:33559528
- pubmed:33685091
- pubmed:33715333
- pubmed:33782420
- pubmed:33811074
- pubmed:33958485
- pubmed:34065827
- pubmed:34071686
- pubmed:34102274
- pubmed:6317292
- pubmed:7224729
- pubmed:74611
- pubmed:7836930
- pubmed:9276764
- reaxys:2224724
- wikipedia.en:Prostaglandin_E2
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from prostaglandin E2
Phenotype where environments contain prostaglandin E2
Phenotype modified by environments containing prostaglandin E2
Phenotype affecting prostaglandin E2
Human Disease Model